668PUpdated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B
Yuki, S, Shinozaki, K, Kashiwada, T, Kusumoto, T, Iwatsuki, M, Satake, H, Tokunaga, S, Emi, Y, Makiyama, A, Kawamoto, Y, Komatsu, Y, Shimokawa, M, Saeki, H, Oki, E, Baba, H, Maehara, YVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.052
Date:
October, 2018
File:
PDF, 79 KB
2018